▶ 調査レポート

分岐部病変治療の世界市場(~2026年)

• 英文タイトル:Global Bifurcation Lesions Treatment Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。分岐部病変治療の世界市場(~2026年) / Global Bifurcation Lesions Treatment Market Size, Status and Forecast 2020-2026 / MRC2-11QY11041資料のイメージです。• レポートコード:MRC2-11QY11041
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、97ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は分岐部病変治療のグローバル市場について調査・分析したレポートです。種類別(Tステント、キュロット、クラッシュ、Vステント、Yステント、ジェイルドバルーン)市場規模、用途別(冠状血管、末梢血管)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別分岐部病変治療の競争状況、市場シェア
・世界の分岐部病変治療市場:種類別市場規模 2015年-2020年(Tステント、キュロット、クラッシュ、Vステント、Yステント、ジェイルドバルーン)
・世界の分岐部病変治療市場:種類別市場規模予測 2021年-2026年(Tステント、キュロット、クラッシュ、Vステント、Yステント、ジェイルドバルーン)
・世界の分岐部病変治療市場:用途別市場規模 2015年-2020年(冠状血管、末梢血管)
・世界の分岐部病変治療市場:用途別市場規模予測 2021年-2026年(冠状血管、末梢血管)
・北米の分岐部病変治療市場分析:米国、カナダ
・ヨーロッパの分岐部病変治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの分岐部病変治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の分岐部病変治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの分岐部病変治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Medtronic、Boston Scientific Corporation、Johnson& Johnson Services, Inc、Abbott、C. R. Bard, Inc.、Spectranetics、Terumo Medical Corporation、Cardinal Health
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Bifurcation Lesions Treatment Market
The global Bifurcation Lesions Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Bifurcation Lesions Treatment Scope and Market Size
Bifurcation Lesions Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bifurcation Lesions Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Medtronic
Boston Scientific Corporation
Johnson& Johnson Services, Inc
Abbott
C. R. Bard, Inc.
Spectranetics
Terumo Medical Corporation
Cardinal Health

Market segment by Type, the product can be split into
T Stent
Culotte
Crush
V Stent
Y Stent
Jailed Balloon
Market segment by Application, split into
Coronary Vascular
Peripheral Vascular

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bifurcation Lesions Treatment Revenue
1.4 Market by Type
1.4.1 Global Bifurcation Lesions Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 T Stent
1.4.3 Culotte
1.4.4 Crush
1.4.5 V Stent
1.4.6 Y Stent
1.4.7 Jailed Balloon
1.5 Market by Application
1.5.1 Global Bifurcation Lesions Treatment Market Share by Application: 2020 VS 2026
1.5.2 Coronary Vascular
1.5.3 Peripheral Vascular
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Bifurcation Lesions Treatment Market Perspective (2015-2026)
2.2 Global Bifurcation Lesions Treatment Growth Trends by Regions
2.2.1 Bifurcation Lesions Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bifurcation Lesions Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Bifurcation Lesions Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Bifurcation Lesions Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Bifurcation Lesions Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Bifurcation Lesions Treatment Players by Market Size
3.1.1 Global Top Bifurcation Lesions Treatment Players by Revenue (2015-2020)
3.1.2 Global Bifurcation Lesions Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Bifurcation Lesions Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bifurcation Lesions Treatment Market Concentration Ratio
3.2.1 Global Bifurcation Lesions Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Bifurcation Lesions Treatment Revenue in 2019
3.3 Bifurcation Lesions Treatment Key Players Head office and Area Served
3.4 Key Players Bifurcation Lesions Treatment Product Solution and Service
3.5 Date of Enter into Bifurcation Lesions Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Bifurcation Lesions Treatment Historic Market Size by Type (2015-2020)
4.2 Global Bifurcation Lesions Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Bifurcation Lesions Treatment Market Size by Application (2015-2020)
5.2 Global Bifurcation Lesions Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Bifurcation Lesions Treatment Market Size (2015-2020)
6.2 Bifurcation Lesions Treatment Key Players in North America (2019-2020)
6.3 North America Bifurcation Lesions Treatment Market Size by Type (2015-2020)
6.4 North America Bifurcation Lesions Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Bifurcation Lesions Treatment Market Size (2015-2020)
7.2 Bifurcation Lesions Treatment Key Players in Europe (2019-2020)
7.3 Europe Bifurcation Lesions Treatment Market Size by Type (2015-2020)
7.4 Europe Bifurcation Lesions Treatment Market Size by Application (2015-2020)

8 China
8.1 China Bifurcation Lesions Treatment Market Size (2015-2020)
8.2 Bifurcation Lesions Treatment Key Players in China (2019-2020)
8.3 China Bifurcation Lesions Treatment Market Size by Type (2015-2020)
8.4 China Bifurcation Lesions Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Bifurcation Lesions Treatment Market Size (2015-2020)
9.2 Bifurcation Lesions Treatment Key Players in Japan (2019-2020)
9.3 Japan Bifurcation Lesions Treatment Market Size by Type (2015-2020)
9.4 Japan Bifurcation Lesions Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Bifurcation Lesions Treatment Market Size (2015-2020)
10.2 Bifurcation Lesions Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bifurcation Lesions Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Bifurcation Lesions Treatment Market Size by Application (2015-2020)

11 India
11.1 India Bifurcation Lesions Treatment Market Size (2015-2020)
11.2 Bifurcation Lesions Treatment Key Players in India (2019-2020)
11.3 India Bifurcation Lesions Treatment Market Size by Type (2015-2020)
11.4 India Bifurcation Lesions Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Bifurcation Lesions Treatment Market Size (2015-2020)
12.2 Bifurcation Lesions Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Bifurcation Lesions Treatment Market Size by Type (2015-2020)
12.4 Central & South America Bifurcation Lesions Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Medtronic
13.1.1 Medtronic Company Details
13.1.2 Medtronic Business Overview
13.1.3 Medtronic Bifurcation Lesions Treatment Introduction
13.1.4 Medtronic Revenue in Bifurcation Lesions Treatment Business (2015-2020))
13.1.5 Medtronic Recent Development
13.2 Boston Scientific Corporation
13.2.1 Boston Scientific Corporation Company Details
13.2.2 Boston Scientific Corporation Business Overview
13.2.3 Boston Scientific Corporation Bifurcation Lesions Treatment Introduction
13.2.4 Boston Scientific Corporation Revenue in Bifurcation Lesions Treatment Business (2015-2020)
13.2.5 Boston Scientific Corporation Recent Development
13.3 Johnson& Johnson Services, Inc
13.3.1 Johnson& Johnson Services, Inc Company Details
13.3.2 Johnson& Johnson Services, Inc Business Overview
13.3.3 Johnson& Johnson Services, Inc Bifurcation Lesions Treatment Introduction
13.3.4 Johnson& Johnson Services, Inc Revenue in Bifurcation Lesions Treatment Business (2015-2020)
13.3.5 Johnson& Johnson Services, Inc Recent Development
13.4 Abbott
13.4.1 Abbott Company Details
13.4.2 Abbott Business Overview
13.4.3 Abbott Bifurcation Lesions Treatment Introduction
13.4.4 Abbott Revenue in Bifurcation Lesions Treatment Business (2015-2020)
13.4.5 Abbott Recent Development
13.5 C. R. Bard, Inc.
13.5.1 C. R. Bard, Inc. Company Details
13.5.2 C. R. Bard, Inc. Business Overview
13.5.3 C. R. Bard, Inc. Bifurcation Lesions Treatment Introduction
13.5.4 C. R. Bard, Inc. Revenue in Bifurcation Lesions Treatment Business (2015-2020)
13.5.5 C. R. Bard, Inc. Recent Development
13.6 Spectranetics
13.6.1 Spectranetics Company Details
13.6.2 Spectranetics Business Overview
13.6.3 Spectranetics Bifurcation Lesions Treatment Introduction
13.6.4 Spectranetics Revenue in Bifurcation Lesions Treatment Business (2015-2020)
13.6.5 Spectranetics Recent Development
13.7 Terumo Medical Corporation
13.7.1 Terumo Medical Corporation Company Details
13.7.2 Terumo Medical Corporation Business Overview
13.7.3 Terumo Medical Corporation Bifurcation Lesions Treatment Introduction
13.7.4 Terumo Medical Corporation Revenue in Bifurcation Lesions Treatment Business (2015-2020)
13.7.5 Terumo Medical Corporation Recent Development
13.8 Cardinal Health
13.8.1 Cardinal Health Company Details
13.8.2 Cardinal Health Business Overview
13.8.3 Cardinal Health Bifurcation Lesions Treatment Introduction
13.8.4 Cardinal Health Revenue in Bifurcation Lesions Treatment Business (2015-2020)
13.8.5 Cardinal Health Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Bifurcation Lesions Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Bifurcation Lesions Treatment Revenue
Table 3. Ranking of Global Top Bifurcation Lesions Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bifurcation Lesions Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of T Stent
Table 6. Key Players of Culotte
Table 7. Key Players of Crush
Table 8. Key Players of V Stent
Table 9. Key Players of Y Stent
Table 10. Key Players of Jailed Balloon
Table 11. Global Bifurcation Lesions Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Bifurcation Lesions Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Bifurcation Lesions Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Bifurcation Lesions Treatment Market Share by Regions (2015-2020)
Table 15. Global Bifurcation Lesions Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Bifurcation Lesions Treatment Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Bifurcation Lesions Treatment Market Growth Strategy
Table 21. Main Points Interviewed from Key Bifurcation Lesions Treatment Players
Table 22. Global Bifurcation Lesions Treatment Revenue by Players (2015-2020) (Million US$)
Table 23. Global Bifurcation Lesions Treatment Market Share by Players (2015-2020)
Table 24. Global Top Bifurcation Lesions Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bifurcation Lesions Treatment as of 2019)
Table 25. Global Bifurcation Lesions Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Bifurcation Lesions Treatment Product Solution and Service
Table 28. Date of Enter into Bifurcation Lesions Treatment Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Bifurcation Lesions Treatment Market Size by Type (2015-2020) (Million US$)
Table 31. Global Bifurcation Lesions Treatment Market Size Share by Type (2015-2020)
Table 32. Global Bifurcation Lesions Treatment Revenue Market Share by Type (2021-2026)
Table 33. Global Bifurcation Lesions Treatment Market Size Share by Application (2015-2020)
Table 34. Global Bifurcation Lesions Treatment Market Size by Application (2015-2020) (Million US$)
Table 35. Global Bifurcation Lesions Treatment Market Size Share by Application (2021-2026)
Table 36. North America Key Players Bifurcation Lesions Treatment Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Bifurcation Lesions Treatment Market Share (2019-2020)
Table 38. North America Bifurcation Lesions Treatment Market Size by Type (2015-2020) (Million US$)
Table 39. North America Bifurcation Lesions Treatment Market Share by Type (2015-2020)
Table 40. North America Bifurcation Lesions Treatment Market Size by Application (2015-2020) (Million US$)
Table 41. North America Bifurcation Lesions Treatment Market Share by Application (2015-2020)
Table 42. Europe Key Players Bifurcation Lesions Treatment Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Bifurcation Lesions Treatment Market Share (2019-2020)
Table 44. Europe Bifurcation Lesions Treatment Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Bifurcation Lesions Treatment Market Share by Type (2015-2020)
Table 46. Europe Bifurcation Lesions Treatment Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Bifurcation Lesions Treatment Market Share by Application (2015-2020)
Table 48. China Key Players Bifurcation Lesions Treatment Revenue (2019-2020) (Million US$)
Table 49. China Key Players Bifurcation Lesions Treatment Market Share (2019-2020)
Table 50. China Bifurcation Lesions Treatment Market Size by Type (2015-2020) (Million US$)
Table 51. China Bifurcation Lesions Treatment Market Share by Type (2015-2020)
Table 52. China Bifurcation Lesions Treatment Market Size by Application (2015-2020) (Million US$)
Table 53. China Bifurcation Lesions Treatment Market Share by Application (2015-2020)
Table 54. Japan Key Players Bifurcation Lesions Treatment Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Bifurcation Lesions Treatment Market Share (2019-2020)
Table 56. Japan Bifurcation Lesions Treatment Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Bifurcation Lesions Treatment Market Share by Type (2015-2020)
Table 58. Japan Bifurcation Lesions Treatment Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Bifurcation Lesions Treatment Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Bifurcation Lesions Treatment Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Bifurcation Lesions Treatment Market Share (2019-2020)
Table 62. Southeast Asia Bifurcation Lesions Treatment Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Bifurcation Lesions Treatment Market Share by Type (2015-2020)
Table 64. Southeast Asia Bifurcation Lesions Treatment Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Bifurcation Lesions Treatment Market Share by Application (2015-2020)
Table 66. India Key Players Bifurcation Lesions Treatment Revenue (2019-2020) (Million US$)
Table 67. India Key Players Bifurcation Lesions Treatment Market Share (2019-2020)
Table 68. India Bifurcation Lesions Treatment Market Size by Type (2015-2020) (Million US$)
Table 69. India Bifurcation Lesions Treatment Market Share by Type (2015-2020)
Table 70. India Bifurcation Lesions Treatment Market Size by Application (2015-2020) (Million US$)
Table 71. India Bifurcation Lesions Treatment Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Bifurcation Lesions Treatment Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Bifurcation Lesions Treatment Market Share (2019-2020)
Table 74. Central & South America Bifurcation Lesions Treatment Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Bifurcation Lesions Treatment Market Share by Type (2015-2020)
Table 76. Central & South America Bifurcation Lesions Treatment Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Bifurcation Lesions Treatment Market Share by Application (2015-2020)
Table 78. Medtronic Company Details
Table 79. Medtronic Business Overview
Table 80. Medtronic Product
Table 81. Medtronic Revenue in Bifurcation Lesions Treatment Business (2015-2020) (Million US$)
Table 82. Medtronic Recent Development
Table 83. Boston Scientific Corporation Company Details
Table 84. Boston Scientific Corporation Business Overview
Table 85. Boston Scientific Corporation Product
Table 86. Boston Scientific Corporation Revenue in Bifurcation Lesions Treatment Business (2015-2020) (Million US$)
Table 87. Boston Scientific Corporation Recent Development
Table 88. Johnson& Johnson Services, Inc Company Details
Table 89. Johnson& Johnson Services, Inc Business Overview
Table 90. Johnson& Johnson Services, Inc Product
Table 91. Johnson& Johnson Services, Inc Revenue in Bifurcation Lesions Treatment Business (2015-2020) (Million US$)
Table 92. Johnson& Johnson Services, Inc Recent Development
Table 93. Abbott Company Details
Table 94. Abbott Business Overview
Table 95. Abbott Product
Table 96. Abbott Revenue in Bifurcation Lesions Treatment Business (2015-2020) (Million US$)
Table 97. Abbott Recent Development
Table 98. C. R. Bard, Inc. Company Details
Table 99. C. R. Bard, Inc. Business Overview
Table 100. C. R. Bard, Inc. Product
Table 101. C. R. Bard, Inc. Revenue in Bifurcation Lesions Treatment Business (2015-2020) (Million US$)
Table 102. C. R. Bard, Inc. Recent Development
Table 103. Spectranetics Company Details
Table 104. Spectranetics Business Overview
Table 105. Spectranetics Product
Table 106. Spectranetics Revenue in Bifurcation Lesions Treatment Business (2015-2020) (Million US$)
Table 107. Spectranetics Recent Development
Table 108. Terumo Medical Corporation Company Details
Table 109. Terumo Medical Corporation Business Overview
Table 110. Terumo Medical Corporation Product
Table 111. Terumo Medical Corporation Revenue in Bifurcation Lesions Treatment Business (2015-2020) (Million US$)
Table 112. Terumo Medical Corporation Recent Development
Table 113. Cardinal Health Business Overview
Table 114. Cardinal Health Product
Table 115. Cardinal Health Company Details
Table 116. Cardinal Health Revenue in Bifurcation Lesions Treatment Business (2015-2020) (Million US$)
Table 117. Cardinal Health Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bifurcation Lesions Treatment Market Share by Type: 2020 VS 2026
Figure 2. T Stent Features
Figure 3. Culotte Features
Figure 4. Crush Features
Figure 5. V Stent Features
Figure 6. Y Stent Features
Figure 7. Jailed Balloon Features
Figure 8. Global Bifurcation Lesions Treatment Market Share by Application: 2020 VS 2026
Figure 9. Coronary Vascular Case Studies
Figure 10. Peripheral Vascular Case Studies
Figure 11. Bifurcation Lesions Treatment Report Years Considered
Figure 12. Global Bifurcation Lesions Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Bifurcation Lesions Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Bifurcation Lesions Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Bifurcation Lesions Treatment Market Share by Players in 2019
Figure 17. Global Top Bifurcation Lesions Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bifurcation Lesions Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Bifurcation Lesions Treatment Revenue in 2019
Figure 19. North America Bifurcation Lesions Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Bifurcation Lesions Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Bifurcation Lesions Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Bifurcation Lesions Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Bifurcation Lesions Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Bifurcation Lesions Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Bifurcation Lesions Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed